AVLN

Avalyn Pharma Inc. - common stock (AVLN)

About Avalyn Pharma Inc. - common stock (AVLN)

Avalyn Pharma, Inc. operates as a clinical-stage biopharmaceutical company. It engages in developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases (ILDs). The company was founded by Richard Glenn Vincent, Mark W. Surber, and Michael J. Kamdar on May 27, 2011 and is headquartered in Boston, MA.

Details

Daily high

$38.34

Daily low

$34.90

Price at open

$35.21

52 Week High

$40.17

52 Week Low

$18.00

Market cap

1.7B

Dividend yield

Volume

243,509

Avg. volume

193,061

P/E ratio

Avalyn Pharma Inc. - common stock News